100 Protocol Renal Allograft Biopsies at 10 Years: First Look at the Tacrolimus Era
12-Month Athena Study: Everolimus Vs. Standard Regimen in De Novo Renal Transplant Recipients
2-Year Results on Renal Function and Safety for Everolimus plus Reduced-Exposure Calcineurin Inhibitor in Living Donor Kidney Transplant Recipients
24 Month Post Transplantation Follow Up of the Certitem Trial
2B4 Expression on Human CD4+ Memory T Cells Is Associated With Functional Impairment
A 10 Min “No-Touch” Time – Is It Enough in DCD? A DCD Animal Study
A 52-Week, Multicenter, Prospective, Observational, Non-Interventional, Open-Label Study to Assess the Effectiveness, Safety and Tolerability of Everolimus in Kidney Transplant Patients in Taiwan
A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation
A Common Gene Signature Across Multiple Studies Identifies Biomarkers and Functional Regulation in Tolerance to Renal Allograft
A Comparative Analysis of Histological Scoring in Living Donor Renal Transplants from Donors Above and Below 60 Years of Age
2015 American Transplant Congress
May 2-6, 2015 in Philadelphia, Pennsylvania
For more information, visit The Official 2015 ATC Congress site.